Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Brenda is a senior consultant in a new practice group within Milliman that is solely dedicated to serving the pricing as well as payer strategy and analytic needs of biopharmaceutical, medical device, and diagnostic companies.
Brenda has more than 10 years of executive biopharmaceutical strategy experience gained at Eli Lilly and Company and Roche Diagnostics Corporation. During her tenure at those companies, she held leadership positions focused on pricing and payer marketing strategy. Her experience at the global level includes pricing strategy, payer market research, and payer marketing. She also led pricing strategy and tool development, IHN and GPO contract negotiations, value proposition, and ROI strategy for the U.S. diagnostics market.
Brenda's expertise spans multiple therapeutic classes in hospital products, retail products, oncology, and diagnostics, and includes product launch experience with a focus on incorporating robust market access strategy for products in Phase III clinical development. She has expertise in development and implementation of negotiation strategies, pricing strategies, payer segmentation, payer value propositions, health economic tactics, and value assessments of new chemical entities. Through her skill set and client experience, she is able to deliver creative revenue optimizing strategies that are actionable and sustainable.